In this issue:
- Radiation therapy for ductal carcinoma in situ in Australia and New Zealand
- Breast cancer-specific survival by molecular subtype
- Psychosocial characteristics, support care needs and QoL affect survival
- Breast density notification in South Australia
- Resection margin width and local recurrence after breast-conserving surgery
- Timing of nivolumab for early TNBC
- Ribociclib + endocrine therapy in HR+/HER2- early breast cancer
- Outcomes and treatment patterns for stage I HER2+ breast cancer
- Comparison of metastatic invasive lobular and ductal carcinoma
- Adjuvant atezolizumab for early TNBC
Please login below to download this issue (PDF)